Navigation Links
Bisphosphonates to Treat Multiple Myeloma

Regarding the use of bisphosphonates in treatment or prevention of bone diseases in Multiple Myeloma (MM), a consensus report has been issued by the Mayo Clinic's// multiple myeloma (MM) research team. This report deals with several controversial issues, like the type of bisphosphonate to be used and the duration of such therapy. This is published in the August issue of Mayo Clinic Proceedings.

"It was imperative that we address the issue that has been under recent intense debate due to patient safety concerns," said Martha Lacy, M.D., Mayo Clinic hematologist and lead author of the statement. "These drugs have far-ranging effects that raised concerns in the medical field, so we brought together the relevant specialists to develop a set of best practice recommendations. We published them in Mayo Clinic Proceedings in order to provide other physicians the benefit of our shared knowledge."

The Mayo Clinic team provided recommendations for the myeloma patients for whom bisphosphonates are indicated. They said pamidronate should be the bisphosphonate of choice for patients who are starting therapy, over the newer, more potent drug zoledronic acid, which is more frequently associated with serious damage to jaw bones. Also in the interest of safety, the team recommended that patients without active disease stop bisphosphonate therapy after two years, and patients with active disease reduce the frequency at which the drugs are given.

MM is a malignant plasma cell disorder that is diagnosed in more than 15,000 people each year in the United States, and which causes more than 11,000 deaths. There are a variety of treatment options for MM, but it remains an incurable disease with current emphasis placed on enhancing quality of life while the cure is sought.

Because bone destruction causes significant problems for MM patients, and painful results include osteoporosis, lytic bone disease and skeletal fractures, clinicians seek to treat th
'"/>




Page: 1 2

Related medicine news :

1. Drugs With Bisphosphonates Packs Osteonecrosis Risk
2. Advances in Treatment of Cataracts
3. Recommendations for Treatment of Blood Pressue
4. New FDA Approved Drug To Treat Migraine
5. Treatment for Menieres disease
6. Treatment for pre-menstrual syndrome is ineffective
7. Angiotensin-II-receptor blockers - Treat kidney failure
8. Cipro Has Cheaper Cousins to Treat Anthrax
9. Better Treatment for obesity
10. Gene Treatment for Heart Disease
11. Cyclosporin A Treats Leukemia Complications
Post Your Comments:
(Date:10/10/2008)...Newswire/ -- Public interest,advocates(1) welcomed...decisions on the threats posed by mercury to human... 2nd UNEP(2) Open Ended Working Group (OEWG2) on,M... of a global framework,on mercury, in preparation ...09, where it will be decided whether a global lega...
(Date:10/10/2008)...Technology Evolution: Smarter Solutions for Better... (PRWEB) September 17, 2008 -- The New Jersey and ...e Information Management Systems Society ( HIMSS )...mation technology professionals together for a two...echnology Evolution: Smarter Solutions for Better ...
(Date:10/10/2008)... Johns Hopkins University School,of Medicine is la...ptimizing Adjuvant Breast Cancer Strategies: From ...ent key research data on the latest advances in,br...ents in the treatment of breast cancer have,led to...ons that are,increasingly tailored to the specific...
(Date:10/9/2008)...e Accredited Course for,Non-Dermatologists about D...ovember 1, 2008 at the Royal Sonesta Hotel Boston,...e-USNewswire/ -- The Melanoma,Foundation of New En... are,co-sponsoring an Accreditation Council for Co...e non-dermatologists on the detection and manageme...
Breaking Medicine News(10 mins):Health News:Elements for a UN Global Framework on Mercury Agreed to 2Health News:HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference 2Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2Health News:Paul Sullivan's Legacy: An Early Warning Program for Detecting Melanoma Before It's Too Late 2
...ked, President A.P.J. Abdul Kalam Thursday said th...ill women// who have no home. "While mental illne...themselves but also for their families, it becomes...ir families," Kalam said here at the beginning of ...
...ation of kidney diseases worldwide. According to s...are in the throes of kidney related ailments. Rep...o avoid kidney transplant is to detect the disease...s simply unaffordable for majority of the people i...
...e physicians are knowledgeable about women’s sleep...’ sleep problems. The survey issued by American Co...). It was found that most pulmonary/critical care ...erns of their female patients and are advising app...
...tt, urging the Commonwealth to convince the States...nd performance benchmarks for medical training in ... (AHCA) negotiations. The current AHCA expires i... the next agreement commence soon. AMA President...
Other Medicine News:Health News:Nearly 2,500 Mentally Ill Women in Delhi are Destitute: Abdul Kalam 2Health News:Doctors Not Drowsy When Treating Women’s Sleep Issue 2Health News:Doctors Not Drowsy When Treating Women’s Sleep Issue 3
(Date:10/8/2008)...(R) Element(TM) Platinum Chromium ...ewswire-FirstCall/ -- Boston Scientific,Corporatio...ted enrollment in,the PERSEUS trial, designed to e...ement(TM) paclitaxel-eluting coronary stent. The P...patients at 100 U.S. and,international centers sin...
(Date:10/7/2008)...etheus Laboratories Inc., a,specialty pharmaceutic...lopment of PROMETHEUS(R) IBS Diagnostic, the first...(IBS). The findings suggest measurable,differences...od samples,between IBS and non-IBS patients. The i... proprietary algorithm, led to the development of ...
(Date:10/7/2008)...e Osteoarthritis Research Society,International,s ...Newswire/ -- Ferring Pharmaceuticals Inc.,recently...thritis of the,Knee, showing that EUFLEXXA(R) (1% ...molecular weight form of intra-articular hyaluroni...ine (IA-saline) for the relief,of pain in knee ost...
(Date:10/7/2008)... taken once-daily significantly,improved the sympt... /- Shire plc (LSE: SHP,Na...al company, today,announced that a study published... Psychiatry found once-daily VYVANSE significantly... (ADHD) symptoms in adults within,the first week o...
Breaking Medicine Technology:Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 2Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 4Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 2Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 3Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 4Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 2Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 3Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 4Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 5Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 6About one quarter of women with HIV want to become pregnant 12652 1About one quarter of women with HIV want to become pregnant 12652 2About one quarter of women with HIV want to become pregnant 12652 3About one quarter of women with HIV want to become pregnant 12652 4Danaher to Present at Citigroup Global Industrial Manufacturing Conference 12649 1Three Year Analysis of Treatment Efficacy Cosmesis and Toxicity Support use of the Hologic Mammosite Radiation Therapy System 1428 1Three Year Analysis of Treatment Efficacy Cosmesis and Toxicity Support use of the Hologic Mammosite Radiation Therapy System 1428 2Three Year Analysis of Treatment Efficacy Cosmesis and Toxicity Support use of the Hologic Mammosite Radiation Therapy System 1428 3Three Year Analysis of Treatment Efficacy Cosmesis and Toxicity Support use of the Hologic Mammosite Radiation Therapy System 1428 4Antibiotic Use in Dementia Patients Questioned 12644 1Antibiotic Use in Dementia Patients Questioned 12644 2Antibiotic Use in Dementia Patients Questioned 12644 3
...essed protein,protects human pancreatic cancer cel...g one of the body,s natural defenses against,out-o...ty of Texas,M. D. Anderson Cancer Center report in...he protein tissue transglutaminase, known by the a...archers at M. D. Anderson and,elsewhere to be over...
...Clinical studies have,shown (1) similar rates of n...uenza patients being treated with Tamiflu compared...za. Furthermore,recent data derived from US healt...101,000 influenza patients treated with Tamiflu,an...lu have shown,that the Tamiflu treated patients sh...
Other Medicine Technology:Protein Found to Shield Pancreatic Cancer Cells from,Self-Destruction 2Protein Found to Shield Pancreatic Cancer Cells from,Self-Destruction 3New Data from the US and Japan Support: No Established Causal Link,Between Neuropsychiatric Symptoms and Treatment with Tamiflu US,Databases Indicate Psychiatric Symptoms Lower in Influenza Patients,Taking Tamiflu Versus Those Not Taking Tamiflu 2New Data from the US and Japan Support: No Established Causal Link,Between Neuropsychiatric Symptoms and Treatment with Tamiflu US,Databases Indicate Psychiatric Symptoms Lower in Influenza Patients,Taking Tamiflu Versus Those Not Taking Tamiflu 3New Data from the US and Japan Support: No Established Causal Link,Between Neuropsychiatric Symptoms and Treatment with Tamiflu US,Databases Indicate Psychiatric Symptoms Lower in Influenza Patients,Taking Tamiflu Versus Those Not Taking Tamiflu 4
For children up to 4 years of age 11 mm internal diameter of the cornea part. Designed to work with argon/YAG Lasers.
...The HAAG-STREIT OM 900 Ophthalmometer uses a class...h meets the three requirements of Helmholtz: 1. Th...tance between the Ophthalmometer and the measured ...ent of the distance between the Ophthalmometer and...
Advanced Corneal Topography System with integrated Keratometer. Keratometric and topographic measurements all in one instrument.
The best combination with the Haag-Streit 900 Slitlamps. For examination of the entire fundus, the vitreous and the iridocorneal angle. For children up to 4 years of age. 11 mm internal diameter of t
Medicine Products: